Pathways Knowlegdes

Necessitatibus eius consequatur ex aliquid fuga eum quidem sint consectetur velit

Pathway DOIs Note
Drug ADME

Accession ID: Reactome:R-BTA-9748784
  • 10.1002/jps.21009
  • 10.2967/jnmt.117.199638
 Currie GM. Pharmacology, Part 2: Introduction to Pharmacokinetics. J Nucl Med Technol. 2018 Sep;46(3):221–30. doi: 10.2967/jnmt.117.199638. PMID: 29724803.; Ruiz-Garcia A, Bermejo M, Moss A, Casabo VG. Pharmacokinetics in Drug Discovery. Journal of Pharmaceutical Sciences. 2008 Feb;97(2):654–90. doi: 10.1002/jps.21009.; Pallasch TJ. Principles of pharmacotherapy: II. Pharmacokinetics. Anesth Prog. 1988 Jul;35(4):133–46. PMID: 3046441; PMCID: PMC2167950.
Azathioprine ADME

Accession ID: Reactome:R-CFA-9748787
  • 10.1016/s1542-3565(04)00344-1
  • 10.1136/gut.39.3.401
  • 10.3389/fphar.2020.582291
  • 10.3748/wjg.v22.i20.4794
 Tominaga K, Sugaya T, Tanaka T, Kanazawa M, Iijima M, Irisawa A. Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases. Front Pharmacol. 2020;11():582291. PMID: 33584261; PMCID: PMC7878672.; Axelrad JE, Lichtiger S, Yajnik V. Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol. 2016 May 28;22(20):4794–801. PMID: 27239106; PMCID: PMC4873872.; Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol. 2004 Sep;2(9):731–43. doi: 10.1016/s1542-3565(04)00344-1. PMID: 15354273.; Cuffari C, Théorêt Y, Latour S, Seidman G. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity. Gut. 1996 Sep;39(3):401–6. PMID: 8949645; PMCID: PMC1383347.
Drug ADME

Accession ID: Reactome:R-RNO-9748784
  • 10.1002/jps.21009
  • 10.2967/jnmt.117.199638
 Currie GM. Pharmacology, Part 2: Introduction to Pharmacokinetics. J Nucl Med Technol. 2018 Sep;46(3):221–30. doi: 10.2967/jnmt.117.199638. PMID: 29724803.; Ruiz-Garcia A, Bermejo M, Moss A, Casabo VG. Pharmacokinetics in Drug Discovery. Journal of Pharmaceutical Sciences. 2008 Feb;97(2):654–90. doi: 10.1002/jps.21009.; Pallasch TJ. Principles of pharmacotherapy: II. Pharmacokinetics. Anesth Prog. 1988 Jul;35(4):133–46. PMID: 3046441; PMCID: PMC2167950.
Drug ADME

Accession ID: Reactome:R-SCE-9748784
  • 10.1002/jps.21009
  • 10.2967/jnmt.117.199638
 Currie GM. Pharmacology, Part 2: Introduction to Pharmacokinetics. J Nucl Med Technol. 2018 Sep;46(3):221–30. doi: 10.2967/jnmt.117.199638. PMID: 29724803.; Ruiz-Garcia A, Bermejo M, Moss A, Casabo VG. Pharmacokinetics in Drug Discovery. Journal of Pharmaceutical Sciences. 2008 Feb;97(2):654–90. doi: 10.1002/jps.21009.; Pallasch TJ. Principles of pharmacotherapy: II. Pharmacokinetics. Anesth Prog. 1988 Jul;35(4):133–46. PMID: 3046441; PMCID: PMC2167950.
Azathioprine ADME

Accession ID: Reactome:R-SPO-9748787
  • 10.1016/s1542-3565(04)00344-1
  • 10.1136/gut.39.3.401
  • 10.3389/fphar.2020.582291
  • 10.3748/wjg.v22.i20.4794
 Tominaga K, Sugaya T, Tanaka T, Kanazawa M, Iijima M, Irisawa A. Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases. Front Pharmacol. 2020;11():582291. PMID: 33584261; PMCID: PMC7878672.; Axelrad JE, Lichtiger S, Yajnik V. Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol. 2016 May 28;22(20):4794–801. PMID: 27239106; PMCID: PMC4873872.; Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol. 2004 Sep;2(9):731–43. doi: 10.1016/s1542-3565(04)00344-1. PMID: 15354273.; Cuffari C, Théorêt Y, Latour S, Seidman G. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity. Gut. 1996 Sep;39(3):401–6. PMID: 8949645; PMCID: PMC1383347.
Drug ADME

Accession ID: Reactome:R-SSC-9748784
  • 10.1002/jps.21009
  • 10.2967/jnmt.117.199638
 Currie GM. Pharmacology, Part 2: Introduction to Pharmacokinetics. J Nucl Med Technol. 2018 Sep;46(3):221–30. doi: 10.2967/jnmt.117.199638. PMID: 29724803.; Ruiz-Garcia A, Bermejo M, Moss A, Casabo VG. Pharmacokinetics in Drug Discovery. Journal of Pharmaceutical Sciences. 2008 Feb;97(2):654–90. doi: 10.1002/jps.21009.; Pallasch TJ. Principles of pharmacotherapy: II. Pharmacokinetics. Anesth Prog. 1988 Jul;35(4):133–46. PMID: 3046441; PMCID: PMC2167950.
Drug ADME

Accession ID: Reactome:R-CFA-9748784
  • 10.1002/jps.21009
  • 10.2967/jnmt.117.199638
 Currie GM. Pharmacology, Part 2: Introduction to Pharmacokinetics. J Nucl Med Technol. 2018 Sep;46(3):221–30. doi: 10.2967/jnmt.117.199638. PMID: 29724803.; Ruiz-Garcia A, Bermejo M, Moss A, Casabo VG. Pharmacokinetics in Drug Discovery. Journal of Pharmaceutical Sciences. 2008 Feb;97(2):654–90. doi: 10.1002/jps.21009.; Pallasch TJ. Principles of pharmacotherapy: II. Pharmacokinetics. Anesth Prog. 1988 Jul;35(4):133–46. PMID: 3046441; PMCID: PMC2167950.
Azathioprine ADME

Accession ID: Reactome:R-DRE-9748787
  • 10.1016/s1542-3565(04)00344-1
  • 10.1136/gut.39.3.401
  • 10.3389/fphar.2020.582291
  • 10.3748/wjg.v22.i20.4794
 Tominaga K, Sugaya T, Tanaka T, Kanazawa M, Iijima M, Irisawa A. Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases. Front Pharmacol. 2020;11():582291. PMID: 33584261; PMCID: PMC7878672.; Axelrad JE, Lichtiger S, Yajnik V. Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol. 2016 May 28;22(20):4794–801. PMID: 27239106; PMCID: PMC4873872.; Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol. 2004 Sep;2(9):731–43. doi: 10.1016/s1542-3565(04)00344-1. PMID: 15354273.; Cuffari C, Théorêt Y, Latour S, Seidman G. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity. Gut. 1996 Sep;39(3):401–6. PMID: 8949645; PMCID: PMC1383347.
Azathioprine ADME

Accession ID: Reactome:R-DDI-9748787
  • 10.1016/s1542-3565(04)00344-1
  • 10.1136/gut.39.3.401
  • 10.3389/fphar.2020.582291
  • 10.3748/wjg.v22.i20.4794
 Tominaga K, Sugaya T, Tanaka T, Kanazawa M, Iijima M, Irisawa A. Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases. Front Pharmacol. 2020;11():582291. PMID: 33584261; PMCID: PMC7878672.; Axelrad JE, Lichtiger S, Yajnik V. Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol. 2016 May 28;22(20):4794–801. PMID: 27239106; PMCID: PMC4873872.; Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol. 2004 Sep;2(9):731–43. doi: 10.1016/s1542-3565(04)00344-1. PMID: 15354273.; Cuffari C, Théorêt Y, Latour S, Seidman G. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity. Gut. 1996 Sep;39(3):401–6. PMID: 8949645; PMCID: PMC1383347.
Azathioprine ADME

Accession ID: Reactome:R-DME-9748787
  • 10.1016/s1542-3565(04)00344-1
  • 10.1136/gut.39.3.401
  • 10.3389/fphar.2020.582291
  • 10.3748/wjg.v22.i20.4794
 Tominaga K, Sugaya T, Tanaka T, Kanazawa M, Iijima M, Irisawa A. Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases. Front Pharmacol. 2020;11():582291. PMID: 33584261; PMCID: PMC7878672.; Axelrad JE, Lichtiger S, Yajnik V. Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol. 2016 May 28;22(20):4794–801. PMID: 27239106; PMCID: PMC4873872.; Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol. 2004 Sep;2(9):731–43. doi: 10.1016/s1542-3565(04)00344-1. PMID: 15354273.; Cuffari C, Théorêt Y, Latour S, Seidman G. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity. Gut. 1996 Sep;39(3):401–6. PMID: 8949645; PMCID: PMC1383347.
Azathioprine ADME

Accession ID: Reactome:R-HSA-9748787
  • 10.1016/s1542-3565(04)00344-1
  • 10.1136/gut.39.3.401
  • 10.3389/fphar.2020.582291
  • 10.3748/wjg.v22.i20.4794
 Tominaga K, Sugaya T, Tanaka T, Kanazawa M, Iijima M, Irisawa A. Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases. Front Pharmacol. 2020;11():582291. PMID: 33584261; PMCID: PMC7878672.; Axelrad JE, Lichtiger S, Yajnik V. Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol. 2016 May 28;22(20):4794–801. PMID: 27239106; PMCID: PMC4873872.; Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol. 2004 Sep;2(9):731–43. doi: 10.1016/s1542-3565(04)00344-1. PMID: 15354273.; Cuffari C, Théorêt Y, Latour S, Seidman G. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity. Gut. 1996 Sep;39(3):401–6. PMID: 8949645; PMCID: PMC1383347.
Drug ADME

Accession ID: Reactome:R-SPO-9748784
  • 10.1002/jps.21009
  • 10.2967/jnmt.117.199638
 Currie GM. Pharmacology, Part 2: Introduction to Pharmacokinetics. J Nucl Med Technol. 2018 Sep;46(3):221–30. doi: 10.2967/jnmt.117.199638. PMID: 29724803.; Ruiz-Garcia A, Bermejo M, Moss A, Casabo VG. Pharmacokinetics in Drug Discovery. Journal of Pharmaceutical Sciences. 2008 Feb;97(2):654–90. doi: 10.1002/jps.21009.; Pallasch TJ. Principles of pharmacotherapy: II. Pharmacokinetics. Anesth Prog. 1988 Jul;35(4):133–46. PMID: 3046441; PMCID: PMC2167950.
Azathioprine ADME

Accession ID: Reactome:R-BTA-9748787
  • 10.1016/s1542-3565(04)00344-1
  • 10.1136/gut.39.3.401
  • 10.3389/fphar.2020.582291
  • 10.3748/wjg.v22.i20.4794
 Tominaga K, Sugaya T, Tanaka T, Kanazawa M, Iijima M, Irisawa A. Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases. Front Pharmacol. 2020;11():582291. PMID: 33584261; PMCID: PMC7878672.; Axelrad JE, Lichtiger S, Yajnik V. Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol. 2016 May 28;22(20):4794–801. PMID: 27239106; PMCID: PMC4873872.; Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol. 2004 Sep;2(9):731–43. doi: 10.1016/s1542-3565(04)00344-1. PMID: 15354273.; Cuffari C, Théorêt Y, Latour S, Seidman G. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity. Gut. 1996 Sep;39(3):401–6. PMID: 8949645; PMCID: PMC1383347.
Drug ADME

Accession ID: Reactome:R-CEL-9748784
  • 10.1002/jps.21009
  • 10.2967/jnmt.117.199638
 Currie GM. Pharmacology, Part 2: Introduction to Pharmacokinetics. J Nucl Med Technol. 2018 Sep;46(3):221–30. doi: 10.2967/jnmt.117.199638. PMID: 29724803.; Ruiz-Garcia A, Bermejo M, Moss A, Casabo VG. Pharmacokinetics in Drug Discovery. Journal of Pharmaceutical Sciences. 2008 Feb;97(2):654–90. doi: 10.1002/jps.21009.; Pallasch TJ. Principles of pharmacotherapy: II. Pharmacokinetics. Anesth Prog. 1988 Jul;35(4):133–46. PMID: 3046441; PMCID: PMC2167950.
Drug ADME

Accession ID: Reactome:R-GGA-9748784
  • 10.1002/jps.21009
  • 10.2967/jnmt.117.199638
 Currie GM. Pharmacology, Part 2: Introduction to Pharmacokinetics. J Nucl Med Technol. 2018 Sep;46(3):221–30. doi: 10.2967/jnmt.117.199638. PMID: 29724803.; Ruiz-Garcia A, Bermejo M, Moss A, Casabo VG. Pharmacokinetics in Drug Discovery. Journal of Pharmaceutical Sciences. 2008 Feb;97(2):654–90. doi: 10.1002/jps.21009.; Pallasch TJ. Principles of pharmacotherapy: II. Pharmacokinetics. Anesth Prog. 1988 Jul;35(4):133–46. PMID: 3046441; PMCID: PMC2167950.
Drug ADME

Accession ID: Reactome:R-MMU-9748784
  • 10.1002/jps.21009
  • 10.2967/jnmt.117.199638
 Currie GM. Pharmacology, Part 2: Introduction to Pharmacokinetics. J Nucl Med Technol. 2018 Sep;46(3):221–30. doi: 10.2967/jnmt.117.199638. PMID: 29724803.; Ruiz-Garcia A, Bermejo M, Moss A, Casabo VG. Pharmacokinetics in Drug Discovery. Journal of Pharmaceutical Sciences. 2008 Feb;97(2):654–90. doi: 10.1002/jps.21009.; Pallasch TJ. Principles of pharmacotherapy: II. Pharmacokinetics. Anesth Prog. 1988 Jul;35(4):133–46. PMID: 3046441; PMCID: PMC2167950.
Drug ADME

Accession ID: Reactome:R-PFA-9748784
  • 10.1002/jps.21009
  • 10.2967/jnmt.117.199638
 Currie GM. Pharmacology, Part 2: Introduction to Pharmacokinetics. J Nucl Med Technol. 2018 Sep;46(3):221–30. doi: 10.2967/jnmt.117.199638. PMID: 29724803.; Ruiz-Garcia A, Bermejo M, Moss A, Casabo VG. Pharmacokinetics in Drug Discovery. Journal of Pharmaceutical Sciences. 2008 Feb;97(2):654–90. doi: 10.1002/jps.21009.; Pallasch TJ. Principles of pharmacotherapy: II. Pharmacokinetics. Anesth Prog. 1988 Jul;35(4):133–46. PMID: 3046441; PMCID: PMC2167950.
Azathioprine ADME

Accession ID: Reactome:R-RNO-9748787
  • 10.1016/s1542-3565(04)00344-1
  • 10.1136/gut.39.3.401
  • 10.3389/fphar.2020.582291
  • 10.3748/wjg.v22.i20.4794
 Tominaga K, Sugaya T, Tanaka T, Kanazawa M, Iijima M, Irisawa A. Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases. Front Pharmacol. 2020;11():582291. PMID: 33584261; PMCID: PMC7878672.; Axelrad JE, Lichtiger S, Yajnik V. Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol. 2016 May 28;22(20):4794–801. PMID: 27239106; PMCID: PMC4873872.; Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol. 2004 Sep;2(9):731–43. doi: 10.1016/s1542-3565(04)00344-1. PMID: 15354273.; Cuffari C, Théorêt Y, Latour S, Seidman G. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity. Gut. 1996 Sep;39(3):401–6. PMID: 8949645; PMCID: PMC1383347.
Azathioprine ADME

Accession ID: Reactome:R-SCE-9748787
  • 10.1016/s1542-3565(04)00344-1
  • 10.1136/gut.39.3.401
  • 10.3389/fphar.2020.582291
  • 10.3748/wjg.v22.i20.4794
 Tominaga K, Sugaya T, Tanaka T, Kanazawa M, Iijima M, Irisawa A. Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases. Front Pharmacol. 2020;11():582291. PMID: 33584261; PMCID: PMC7878672.; Axelrad JE, Lichtiger S, Yajnik V. Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol. 2016 May 28;22(20):4794–801. PMID: 27239106; PMCID: PMC4873872.; Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol. 2004 Sep;2(9):731–43. doi: 10.1016/s1542-3565(04)00344-1. PMID: 15354273.; Cuffari C, Théorêt Y, Latour S, Seidman G. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity. Gut. 1996 Sep;39(3):401–6. PMID: 8949645; PMCID: PMC1383347.
Azathioprine ADME

Accession ID: Reactome:R-SSC-9748787
  • 10.1016/s1542-3565(04)00344-1
  • 10.1136/gut.39.3.401
  • 10.3389/fphar.2020.582291
  • 10.3748/wjg.v22.i20.4794
 Tominaga K, Sugaya T, Tanaka T, Kanazawa M, Iijima M, Irisawa A. Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases. Front Pharmacol. 2020;11():582291. PMID: 33584261; PMCID: PMC7878672.; Axelrad JE, Lichtiger S, Yajnik V. Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol. 2016 May 28;22(20):4794–801. PMID: 27239106; PMCID: PMC4873872.; Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol. 2004 Sep;2(9):731–43. doi: 10.1016/s1542-3565(04)00344-1. PMID: 15354273.; Cuffari C, Théorêt Y, Latour S, Seidman G. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity. Gut. 1996 Sep;39(3):401–6. PMID: 8949645; PMCID: PMC1383347.